Lv72
5000 积分 2024-06-02 加入
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
1个月前
已完结
A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with ‘sandwich’ therapy
1个月前
已关闭
International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
1个月前
已完结
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma
5个月前
已完结
Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent
5个月前
已完结
2016 US lymphoid malignancy statistics by World Health Organization subtypes
5个月前
已完结
Natural killer-cell malignancies: diagnosis and treatment
5个月前
已完结
淋巴瘤PET/CT及PET/MRI显像临床应用指南（2025版）
6个月前
已完结
淋巴瘤PET/CT及PET/MRI显像临床应用指南（2025版）
6个月前
已关闭
Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy
6个月前
已完结
皖公网安备34019202002308
